These findings agree with previous studies showing that hiPSC-derived neurons bearing AD-related mutations in presenilin-1 or amyloid precursor protein show a higher frequency of spontaneous action potential compared to isogenic gene corrected controls, which is reversed via either γ-Secretase or BACE1 inhibition [16]. This evidence concerns the gene APP and Alzheimer disease.